$0.79 0.03 (+3.44%)
11/24/2009 3:59 PM

Antigenics, Inc. (AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Featured Broker Partners